Synthesis and release of platelet-activating factor is inhibited by plasma α1 -proteinase inhibitor or α1 -antichymotrypsin and is stimulated by proteinases

Journal of Experimental Medicine

Volumn 168, Issue 4, 1988, Pages 1293-1306

  Camussi, Giovanni ^a,c   Tetta, Ciro ^a   Bussolino, Federico ^b   Baglionii, Corrado ^d  

^a Laboratorio di Immunopatologia della Cattedra di Nefrologia ^*  (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; CALCIMYCIN; CHYMOTRYPSIN INHIBITOR; ELASTASE; INTERLEUKIN 1; PROTEINASE INHIBITOR; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR;

CELL CULTURE; CHROMATOGRAPHY; HUMAN; HUMAN CELL; PLASMA; PRIORITY JOURNAL;

ALPHA 1-ANTICHYMOTRYPSIN; ALPHA 1-ANTITRYPSIN; BLOOD PROTEINS; CELLS, CULTURED; CHEMICAL FRACTIONATION; CHROMATOGRAPHY, GEL; ENDOPEPTIDASES; ENDOTHELIUM, VASCULAR; HUMAN; INTERLEUKIN-1; MACROPHAGES; NEUTROPHILS; PHAGOCYTOSIS; PLATELET ACTIVATING FACTOR; PROTEASE INHIBITORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR NECROSIS FACTOR;

EID: 0023768482     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.168.4.1293     Document Type: Article

References (32)

1. Demopoulos, C. A., R. N. Pinckard, and D.J. Hanahan. 1979. Platelet-activating factor. Evidence for l-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J. Biol. Chem. 254:9355.
2. Benveniste, J., M. Tence, P. Varenne, J. Bidault, C. Boullet, and J. Polonsky. 1979. Semisynthese et structure proposee du facteur activant les plaquettes (PAF): PAF-acether, un alkyl ether analogue de la lysophosphatidylcholine. C. R. Acad. Sci. (Paris). 289D:1037.
3. Blank, M. L., F. Snyder, W. Byers, B. Brooks, and E. E. Muirhead. 1979. Anti-hypertensive activity of an alkyl ether analog of phosphatidylcholine. Biochem. Biophys. Res. Commun. 90:1191.
4. Benveniste, J., P. M. Henson, and C. G. Cochrane. 1972. Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J. Exp. Med. 136:1356.
5. Mencia-Huerta, J. M., and J. Benveniste. 1979. Platelet activating factor and macrophage. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes. Eur. J. Immunol. 9:409.
6. Camussi, G., I. Pawlowski, F. Bussolino, P. Caldwell, J. Brentjens, and G. Andres. 1983. Release of platelet-activating factor in rabbits with antibody mediated injury of the lung. The role of polymorphonuclear neutrophils and pulmonary endothelial cells. J. Immunol. 131:180.
7. Lynch, J. M., G. Z. Lotner, S.J. Betz, and P. M. Henson. 1979. The release of platelet-activating factor by stimulated rabbit neutrophils. J. Immunol. 123:1219.
8. Chignard, M., J. P. LeCouedic, M. Tence, B. B. Vargaftig, and J. Benveniste. 1979. The role of platelet-activating factor in platelet aggregation. Nature (Lond.). 279:799.
9. Camussi, G., M. Aglietta, F. Malavasi, C. Tetta, W. Piacibello, F. Sanavio, and F. Bussolino. 1983. The release of platelet-activating factor from human endothelial cells in culture. J. Immunol. 131:2397.
10. Prescott, S. M., G. A. Zimmerman, and T. M. Mclntyre. 1984. Human endothelial cells in culture produce platelet-activating factor (l-alkyl-2-acetyl-in-glyceryl-3-phos-phocholine) when stimulated with thrombin. Proc. Natl. Acad. Sci. USA. 81:3534.
11. Movat, H. Z. 1987. Tumor necrosis factor and interleukin-1: role in acute inflammation and microvascular injury. J. Lab. Clin. Med. 110:668.
12. Camussi, G., F. Bussolino, G. Salvidio, and C. Baglioni. 1987. Tumor necrosis factor/cachectin stimulates rat peritoneal macrophages and human endothelial cells to synthesize and release platelet-activating factor. J. Exp. Med. 166:1390.
13. Bussolino, E, G. Camussi, and C. Baglioni. 1988. Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin-la.J. Biol. Chem. 263:11856.
14. Bussolino, E, F. Breviario, M. Aglietta, F. Sanavio, A. Bosia, and E. Dejana. 1987. Studies on the mechanism of interleukin 1 stimulation of platelet activating factor synthesis in human endothelial cells in culture. Biochem. Biophys. Acta. 927:43.
15. Camussi, G. 1986. Potential role of platelet-activating factor in renal pathophysiology. Kidney Int. 29:469.
16. O’Flaherty, R., R. L. Wykle, C. H. Miller, J. C. Lewis, M. Waite, D. A. Bass, C. E. McCall, and L. R. De Chatelet. 1981. l-o-Alkyl-.jn-glyceryl-3-phosphorylcholine. A novel class of neutrophil stimulants. Am. J. Pathol. 103:70.
17. Shaw, J. O., R. N. Pinchard, K. S. Ferrigni, L. McManus, and D. J. Hanahan. 1981. Activation of human neutrophils with l-0-hexadecyl/octadecyl-2-acetyl-.sn-glyceryl-3-phosphorylcholine (platelet activating factor). J. Immunol. 127:1250.
18. Yasaka, T., L. A. Boxer, and R. N. Baehner. 1982. Monocytes aggregation and superoxide anion release in response to formylmethionyl-leucylphenylanine (FMLP) and platelet activating factor (PAF). J. Immunol. 128:1939.
19. Humphrey, D. M., L. McManus, K. Satouchi, D. J. Hanahan, and R. M. Pinckard. 1982. Vasoactive properties of acetyl glyceryl ether phosphorylcholine and analogs. Lab. Invest. 46:422.
20. Beutler, B., and A. Cerami. 1987. Cachectin: more than a tumor necrosis factor. N. Engl. J. Med. 316:379.
21. Wardlow, M. L., C. P. Cox, K. E. Meng, D. E. Greene, and R. S. Farr. 1986. Substrate specificity and partial characterization of the PAF-acylhydrolase in human serum that rapidly inactivates platelet-activating factor. J. Immunol. 136:3441.
22. Blank, M. L., T. C. Lee, V. Fitzgerald, and F. Snyder. 1981. A specific acetylhydrolase for l-alkyl-2-acetyl-fn-glycero-3-phosphocholine (a hypothensive and platelet activating lipid). J. Biol. Chem. 256:175.
23. Johnson, D., and J. Travis. 1978. Structural evidence for methionine at the reactive site of human a-l-proteinase inhibitor. J. Biol Chem. 253:7142.
24. Camussi, G., M. Aglietta, R. Coda, F. Bussolino, W. Piacibello, and C. Tetta. 1981. Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils. Immunology. 42:191.
25. Travis, J., and G. S. Salvesen. 1983. Human plasma proteinase inhibitors. Annu. Rev. Biochem. 52:655.
26. Weitz, J. I., A.J. Huang, S. L. Landman, S. C. Nicholson, and S. C. Silverstein. 1987. Elastase-mediated fibrinogenolysis by chemoattractant-stimulated neutrophils occurs in the presence of physiologic concentrations of antiproteinases. J. Exp. Med. 166:1836.
27. Mclntyre, T. M., S. I. Reinhold, S. M. Prescott, and G. A. Zimmerman. 1987. Protein kinase C activity appears to be required for the synthesis of platelet-activating factor and leukotriene B4 by human neutrophils. J. Biol. Chem. 262:15370.
28. Albert, D. H., and F. Snyder. 1983. Biosynthesis of l-alkyl-2-acetyl-in-glycero-3-phosphocholine (platelet activating factor) from l-alkyl-2-acyl-in-glycero-3-phosphocholine by rat alveolar macrophages. Phospholipase A2 and acetyltransferase during phagocytosis and ionophore stimulation. J. Biol. Chem. 258:97.
29. Davidson, F. E, E. A. Dennis, M. Powell, and J. R. Glenney. 1987. Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids. J. Biol. Chem. 262:1698.
30. Cirino, G., R.J. Flower, J. L. Browning, L. K. Sinclair, and R. B. Pepinsky. 1987. Recombinant human lipocortin 1 inhibits thromboxane release from guinea-pig isolated perfused lung. Nature (Lond.). 328:270.
31. Kohase, M., D. Henriksen-DeStefano, L. T. May, J. Vilcek, and P. B. Sehgal. 1986. Induction of P2-interferon by TNF: a homeostatic mechanism in the control of cell proliferation. Cell. 45:659.
32. 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Natl. Acad. Sci. USA. 84:7251.